Compounds > beta-lactams
Page last updated: 2024-09-04

beta-lactams and Necrotizing Pyelonephritis

beta-lactams has been researched along with Necrotizing Pyelonephritis in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (6.67)29.6817
2010's12 (80.00)24.3611
2020's2 (13.33)2.80

Authors

AuthorsStudies
Almirante, B; Bosch-Nicolau, P; Burgos, J; Marquez-Algaba, E; Pigrau, C; Serra-Pladevall, J; Viñado, B1
Chang, SP; Hung, SH; Lai, CC; Lan, SH; Lin, WT; Lu, LC1
Kiertiburanakul, S; Malaisri, C; Phuphuakrat, A; Santanirand, P; Wibulpolprasert, A1
Cassisa, V; Chenouard, R; Eveillard, M; Kempf, M; Lemarié, C; Pailhoriès, H1
Kim, JH; Kim, MJ; Kim, SB; Sohn, JW; Suh, JW; Yang, KS; Yoon, YK1
Alberola, J; Artero, A; Cano, A; Eiros, JM; Nogueira, JM1
Bilchenko, AV; Chub, OI1
Ersoy, F; Uslu, H; Yılmaz, F1
Kim, JH; Kim, MJ; Sohn, JW; Yang, KS; Yoon, YK1
Aihara, Y; Harada, T; Ito, S; Machida, H; Teranishi, J; Yokota, S1
Bayraktar, B; Dalgic, N; Dincer, E; Pelit, S; Sancar, M1
Ahmed-Bentley, J; Peirano, G; Pitout, JD; Woodford, N1
Chung, MH; Kim, HY; Kim, JY; Kim, MJ; Lee, JS; Lee, MS; Park, DW; Park, YS; Peck, KR; Yeom, JS1
Boisseau, D; Ferry-Blanco, C; Forestier, E; Gros, S; Labe, A; Lecomte, C; Levast, M; Peynaud, D; Rogeaux, O1
Gesser, RM; Jiang, Q; Wells, WG; Woods, GL1

Reviews

1 review(s) available for beta-lactams and Necrotizing Pyelonephritis

ArticleYear
Novel β-Lactam/β-Lactamase inhibitor combinations vs alternative antibiotics in the treatment of complicated urinary tract infections: A meta-analysis of randomized controlled trials.
    Medicine, 2020, Volume: 99, Issue:19

    Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Drug Therapy, Combination; Humans; Pyelonephritis; Randomized Controlled Trials as Topic; Treatment Outcome; Urinary Tract Infections

2020

Trials

3 trial(s) available for beta-lactams and Necrotizing Pyelonephritis

ArticleYear
A randomized controlled trial of sitafloxacin vs. ertapenem as a switch therapy after treatment for acute pyelonephritis caused by extended-spectrum β-lactamase-producing Escherichia coli: A pilot study.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2017, Volume: 23, Issue:8

    Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Humans; Male; Middle Aged; Pilot Projects; Pyelonephritis

2017
Comparison of ertapenem and ceftriaxone therapy for acute pyelonephritis and other complicated urinary tract infections in Korean adults: a randomized, double-blind, multicenter trial.
    Journal of Korean medical science, 2012, Volume: 27, Issue:5

    Topics: Acute Disease; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Double-Blind Method; Ertapenem; Humans; Odds Ratio; Pyelonephritis; Republic of Korea; Risk Factors; Urinary Tract Infections

2012
Treatment of complicated urinary tract infection in adults: combined analysis of two randomized, double-blind, multicentre trials comparing ertapenem and ceftriaxone followed by appropriate oral therapy.
    The Journal of antimicrobial chemotherapy, 2004, Volume: 53 Suppl 2

    Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Double-Blind Method; Drug Administration Schedule; Ertapenem; Female; Gram-Negative Bacteria; Gram-Positive Cocci; Humans; Lactams; Male; Middle Aged; Multicenter Studies as Topic; Pyelonephritis; Randomized Controlled Trials as Topic; Treatment Outcome; Urinary Tract Infections

2004

Other Studies

11 other study(ies) available for beta-lactams and Necrotizing Pyelonephritis

ArticleYear
Risk Factors for Relapse in Acute Bacterial Prostatitis: the Impact of Antibiotic Regimens.
    Microbiology spectrum, 2021, 10-31, Volume: 9, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteriuria; beta-Lactams; Chronic Disease; Drug Resistance, Bacterial; Female; Humans; Male; Middle Aged; Prostatitis; Pyelonephritis; Quinolones; Recurrence; Risk Factors; Trimethoprim, Sulfamethoxazole Drug Combination

2021
Staphylococcus saprophyticus: Which beta-lactam?
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2017, Volume: 65

    Topics: Adolescent; Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Cystitis; Drug Resistance, Multiple, Bacterial; Empirical Research; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pyelonephritis; Staphylococcus saprophyticus; Urinary Tract Infections; Young Adult

2017
The use of cefepime as a carbapenem-sparing antibiotic for treating uncomplicated acute pyelonephritis caused by extended-spectrum β-lactamase producing Escherichia coli.
    Infectious diseases (London, England), 2018, Volume: 50, Issue:3

    Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Cefepime; Cephalosporins; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Hospitals, University; Humans; Male; Middle Aged; Pyelonephritis; Republic of Korea; Retrospective Studies; Risk Factors; Treatment Outcome

2018
Pyelonephritis in pregnancy. How adequate is empirical treatment?
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2013, Volume: 26, Issue:1

    Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactams; Comorbidity; Escherichia coli Infections; Female; Fosfomycin; Hospitals, University; Humans; Inappropriate Prescribing; Microbial Sensitivity Tests; Obstetrics and Gynecology Department, Hospital; Pregnancy; Pregnancy Complications, Infectious; Pyelonephritis; Recurrence; Retrospective Studies; Spain; Treatment Outcome; Young Adult

2013
[Prevalence of Types TEM, SHV and CTX-M βLES Among Pathogens of Chronic Pyelonephritis].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2014, Volume: 59, Issue:11-12

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Chronic Disease; Drug Resistance, Multiple, Bacterial; Female; Genes, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Male; Middle Aged; Plasmids; Pyelonephritis; Young Adult

2014
Ertapenem Associated With Seizures in Treatment of Pyelonephritis in a Chronic Peritoneal Dialysis Patient.
    Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2016, Volume: 20, Issue:1

    Topics: Administration, Intravenous; Anti-Bacterial Agents; beta-Lactams; Drug Dosage Calculations; Ertapenem; Escherichia coli; Humans; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Pyelonephritis; Seizures

2016
Role of piperacillin/tazobactam as a carbapenem-sparing antibiotic for treatment of acute pyelonephritis due to extended-spectrum β-lactamase-producing Escherichia coli.
    International journal of antimicrobial agents, 2017, Volume: 49, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Hospitals, University; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pyelonephritis; Republic of Korea; Retrospective Studies; Survival Analysis; Treatment Failure; Young Adult

2017
Extended-spectrum beta-lactamase-producing bacteria and vesicoureteral reflux in children.
    Pediatrics international : official journal of the Japan Pediatric Society, 2010, Volume: 52, Issue:1

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Escherichia coli Infections; Humans; Infant; Klebsiella Infections; Klebsiella oxytoca; Klebsiella pneumoniae; Male; Pyelonephritis; Recurrence; Urinary Tract Infections; Vesico-Ureteral Reflux

2010
Ertapenem for the treatment of urinary tract infections caused by extended-spectrum β-lactamase-producing bacteria in children.
    Scandinavian journal of infectious diseases, 2011, Volume: 43, Issue:5

    Topics: Adolescent; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Child; Child, Preschool; Community-Acquired Infections; Disk Diffusion Antimicrobial Tests; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Female; Follow-Up Studies; Hospitals; Humans; Infant; Male; Pyelonephritis; Recurrence; Retrospective Studies; Turkey; Urinary Tract Infections

2011
New Delhi metallo-beta-lactamase from traveler returning to Canada.
    Emerging infectious diseases, 2011, Volume: 17, Issue:2

    Topics: Adult; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Canada; Carbapenems; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Fosfomycin; Humans; India; Male; Microbial Sensitivity Tests; Prostatitis; Pyelonephritis; Travel; Urine

2011
[Ertapenem administered intravenously or subcutaneously for urinary tract infections caused by ESBL producing enterobacteriacea].
    Medecine et maladies infectieuses, 2012, Volume: 42, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Ambulatory Care; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cystitis; Drug Evaluation; Ertapenem; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Humans; Injections, Intravenous; Injections, Subcutaneous; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Prostatitis; Pyelonephritis; Recurrence; Retrospective Studies; Risk Factors

2012